Barta, Bálint András https://orcid.org/0000-0001-5619-0438
Ruppert, Mihály
Fröhlich, Klemens Erwin
Cosenza-Contreras, Miguel
Oláh, Attila
Sayour, Alex Ali
Kovács, Krisztián
Karvaly, Gellért Balázs
Biniossek, Martin
Merkely, Béla
Schilling, Oliver
Radovits, Tamás
Funding for this research was provided by:
Nemzeti Kutatási, Fejlesztési és Innovaciós Alap (ÚNKP-20-3-I-SE-1, NVKP_16-1–2016-0017, 2020-4.1.1.-TKP2020, K134939)
Deutsche Forschungsgemeinschaft (SCHI 871/11-1, SCHI 871/15-1, GR 4553/5-1, PA 2807/3-1, INST 39/1244-1 (P12), INST 39/766-3 (Z1), GRK 2606 "ProtPath")
ERA PerMed programme (BMBF)
ERA PerMed programme (01KU1916, 01KU1915A)
German-Israeli Foundation for Scientific Research and Development (grant no. 1444)
Deutschen Konsortium für Translationale Krebsforschung (project Impro-Rec)
Semmelweis University
Article History
Received: 29 May 2021
Accepted: 23 November 2021
First Online: 11 December 2021
Declarations
:
: Our investigation was performed as approved by the Ethics Committee of Hungary for Animal Experimentation, Semmelweis University, Budapest (PEI/001/2374-4/2015) conforming to European Directive 2010/63/EU and the Guide for the Care and Use of Laboratory Animals used by the US National Institutes of Health (Publication No. 85-23, revised 1996).
: This study consists of animal data and is devoid of any human data, thus consent for publication is not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.